Trial intelligence / Profile preview

Evaluation of oral G-CSF effects on gastrointestinal development in preterm infants

IRCT20190622043967N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Sep 2020
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of filgrastim in Gastrointestinal immaturity, sponsored by Iran University of Medical Sciences. Started Sep 2020; status: completed.

02

Drugs

filgrastim
03

Conditions

Gastrointestinal immaturity

Beyond the preview

Go deeper on IRCT20190622043967N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190622043967N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call